BIOMEDRO GmbH is committed to basic medical research, the development of diagnostic test systems, and the carrying out of clinical studies investigating innovative treatment and diagnostic strategies in rheumatic autoimmune diseases. The medical research has a predominant focus on biomarker discovery using sophisticated proteomics approaches such as two-dimensional gel electrophoresis. BIOMEDRO DIAGNOSTICS develops ELISA tests using individual, highly purified recombinant antigens – resulting in hits that are very specific.

Bone Index is one of the most promising Life Science Company in Scandinavia 2014 (Nordic Star Award) and one of Europe’s top new manufacturers of medical devices 2015 (Healthtech Summit). The mission is to reduce the number of osteoporotic fractures by one million globally per year and thus increase the quality of life of families. The aim is bring the diagnostics from special healthcare to primary healthcare with Bindex® point-of-care technology.

Daisygrip is the first hygienically reusable venous tourniquet and has a unique intuitive locking system. The simpler application and disinfection method ensure lasting safety and permanently reduce costs. With daisygrip, every routine blood sample is taken time-efficiently and under hygienic conditions, without changing current treatment procedures.

DST has identified the chances in developing, manufacturing and marketing in vitro tests for point of care diagnostics. Major products of the company are tests based on the FastCheckPOC® platform that require only little amounts of capillary or heparin blood. These tests come as complete kits and do not require any further equipment or readers. The test result becomes visible as an unambiguous patented display after max. 30 minutes. DST’s FastCheckPOC® allergy tests screen specific IgE against multiple airborne or food allergens, respectively and covers 90% of the relevant European allergies.

We Collect the Cells you search for. GILUPI is a specialized medical technology company focused on the development and production of the GILUPI CellCollector® technology, a medical device used in the upstream value chain of molecular diagnostics. GILUPI has developed a unique and proprietary technology platform that represents a major improvement in the harvesting of rare cells, such as circulating tumour cells (“CTCs”) or circulating endothelial cells (“CECs”), directly in the patient’s blood stream (in vivo). Application of the GILUPI technology renders living cells that today can only be harvested in sufficient numbers via biopsies.

IBA GmbH is dedicated to high quality tools for life science research. We provide solutions for the entire production chain of recombinant proteins, from oligo synthesis, cloning, transfection, protein expression and purification, to detection, immobilization and assay. We also deliver new tools for immunology research with a growing line of tag-based reagents for cell isolation. We support our customers in the life sciences industry and academia from early discovery to commercialization. The know-how and innovative approach qualifies IBA as the ideal partner for the pharmaceutical and biotech industry.

Karlsburg has been an internationally distinguished place for diabetes research and treatment since 1930. In combination with the telemedicine system TeleDIAB®, the Karlsburg Diabetes Management System KADIS®, which is the result of 30 years intensive research, supports physicians and patients in their daily efforts to optimize the glycemic control. The services offered by the Diabetes Service Center Karlsburg is ready for use in the ambulatory practice with a number of specialized applications for e.g. education, optimization of glycemic control, prevention and personalized decision support.

Labrox Oy has developed and manufactures a small footprint, versatile and compact multimode plate reader family, with excellent performance featuring all commonly needed detection modes (ABS,LUM,FI,TRF,FP & Upcon). It is available in any combination of detection modes featuring the option of later detection mode upgrades. User-selectable accessories include one- or two-syringe dispenser options and a wide variety of filters and dichroic mirrors. This 6-in-1 multimode reader generates high quality results with all measurement technologies. End-point, kinetic or scanning measurement modes are included which enables various assay type usage.

MDSC (Maru Deployable Shelter & Container Systems) Systems OÜ is specialised in designing and manufacturing all kinds of Special Purpose Containers for military, rescue, medicine and industrial directions. The most recent solution in our product range is mobile medical solutions.

Mech-Sense is a multidisciplinary research centre located at Departments of Gastroenterology and Radiology, Aalborg University Hospital, Denmark. The main competences are within visceral pain and the gastrointestinal system. The mission of Mech-Sense is to foster scientific research, education and innovation for the benefit of patients with gastrointestinal diseases and symptoms hereof. This also includes public and private partnerships. The practical research is performed in 6 complementary and cooperating areas: Neurogastroenterology and Motility, Pancreatology, Pharmacology, Diabetology, Neurophysiology and Imaging.

The portfolio ranges from DR retrofits for existing X-ray systems, CR systems and complete X-ray systems to the mobile detector suitcase solution for outdoor use (e.g. on ships and oil rigs, in remote locations or disaster management). Innovative research and the further development of the dicomPACS® digital image processing software have led to the highly professional dicomPACS®DX-R acquisition software which is an integral part of all digital X-ray solutions. Renowned system integrators (OEMs) are also using individualized versions of this dicomPACS®DX-R acquisition software as a component within their systems with great success.

Oslo Cancer Cluster is a non-profit member organization dedicated to accelerate the development of new cancer diagnostics and medicines through: Local collaboration and international partnerships; Stimulation and support of new innovations and start-up activities; strengthening of our member’s ability to attract capital; Improved clinical trial efficiency for our members; Increase of governmental focus and improved public policies for the cancer community, fostering and attracting the next generation of top talents to cancer R&D and entrepreneurship. In June 2007, the cluster became a Norwegian Centre of Expertise (NCE). Oslo Cancer Cluster has more than 70 members from Northern Europe, representing the entire oncology value chain from bench to bedside.

Share equipment, services, facilities and knowledge with other organizations in the ScanBalt BioRegion. B2B sharing Marketplace for renting out and sell idle capacity, facilities, and staff. On here, we unite supply and demand, and facilitate organizations to generate additional turnover and lower costs through asset sharing. 30 % discounts for members of ScanBalt. The ScanBalt Sharing Marketplace is a product of the collaboration between ScanBalt fmba and FLOOW2 Healthcare, the first Sharing Marketplace for healthcare organizations.

The Steinbeis Transfer Center Personalized Medicine offers support for: • Development and validation of biomarkers • Biostatistical analyses incl. statistical (machine) learning • Diagnostic assay development, quantitative Lateral Flow Assays • Design of experiments and clinical studies (sample size calculations) • Courses in statistics and statistical software • Functional genomics: transcriptomics, metabolomics, genotyping, sequencing • Consulting on patent applications. Key Areas are: • Personalized, predictive medicine (precision medicine) • Development of diagnostic, prognostic and theragnostic markers

Syncom provides the pharmaceutical and biotech industries with custom synthesis solutions. As a global leader Syncom can count leading global pharmaceutical companies as well as small virtual startup companies among our clients. In addition to our pharma activities we serve also the diagnostic, fine chemical, electronic and pigment industries.

United Medix Laboratories Ltd is a Finnish service company providing an extensive selection of laboratory services. We offer comprehensive central laboratory services to the fields of clinical chemistry, clinical microbiology, pathology and genetics as well as to therapeutic drug testing, drugs of abuse testing and drug testing in sports. We also support our customers in local laboratories, covering point-of-care testing and specimen collection services at customer locations.

Our mission is to give people insight into their body and increase wellbeing and quality of life with relatively small effort. Today, the price of DNA sequencing is at a level that enables us to offer the benefits of the latest, cutting-edge science to almost everyone. Our analysis and recommendations are based on the DNA of the bacteria in your gut. It takes about 2 weeks from receiving your stool sample for us to complete the analysis and email you your personalized report. Our report is useful for anyone who wants to improve their quality of life, have more energy and increase life expectancy. Gut bacteria have an important role in extracting extra energy from the food we eat and small precisely targeted changes in diet can have a big impact on well-being. This report can also help manage weight.